Table 3. Analysis of the cellular proteome for oxidised peptides encompassing reported sites of prolyl hydroxylation.
The number of unmodified and singly oxidised peptides containing reported sites of PHD-catalysed hydroxylation were counted over a range of stringency filters. Where multiple reported oxidation sites of one protein occur on separate peptides the number of spectra recorded is a summation of all interrogated peptides. The number of assigned target site prolyl oxidations is indicated in bold; methionine (Met) and alternate oxidation sites, including non-target proline residues (Other) are also presented together with unoxidised peptides for comparison. Stringency filters were applied as follows; PTM assignment confidence as assessed by ambiguity score (AScore:>20) and fragment ion intensity (Ion Intensity:>5%). These filters were applied separately and in combination to derive a list of assigned peptides with confidently localised oxidations. There are no high confidence proline oxidation assignments (i.e., meeting both AScore and Ion Intensity thresholds) of the reported substrates, suggesting a high degree of uncertainty from the software.
# Spectra filtered by confidence of modification site | |||||||
---|---|---|---|---|---|---|---|
Gene ID | Reported site | Assigned | No filter | AScore | Ion Intensity | AScore and Ion Intensity | |
ACACB | P343, P450, P2131 | Unoxidised | 63 | N/A | N/A | N/A | |
ACTB | P307, P322 | P322 | 57 | 7 | 11 | - | |
Met | 4528 | 647 | 4096 | 406 | |||
Other | 336 | 58 | 62 | 7 | |||
Unoxidised | 8650 | N/A | N/A | N/A | |||
ADRB2 | P382*, P395* | Unoxidised | 1 | N/A | N/A | N/A | |
AKT1 | P125, P313*, P318*, P423 | Unoxidised | 160 | N/A | N/A | N/A | |
CENPN | P311 | Unoxidised | 7 | N/A | N/A | N/A | |
EEF2K | P98 | Met | 5 | - | - | - | |
Unoxidised | 41 | N/A | N/A | N/A | |||
FLNA | P2317*, P2324* | P2324 | 2 | - | - | - | |
Other | 1 | - | - | - | |||
Unoxidised | 562 | N/A | N/A | N/A | |||
FOXO3 | P426*, P437* | Unoxidised | 4 | N/A | N/A | N/A | |
NDRG3 | P294 | Met | 13 | 5 | - | - | |
Unoxidised | 49 | N/A | N/A | N/A | |||
PDE4D | P29, P382, P419 | Met | 14 | 13 | 9 | 9 | |
Other | 1 | - | - | - | |||
Unoxidised | 23 | N/A | N/A | N/A | |||
PKM | P403*, P408* | P403 | 3 | 1 | - | - | |
P408 | 5 | - | - | - | |||
Other | 5 | - | - | - | |||
Unoxidised | 3394 | N/A | N/A | N/A | |||
PPP2R2A | P319 | Met | 50 | 11 | 26 | 11 | |
Other | 18 | - | - | - | |||
Unoxidised | 119 | N/A | N/A | N/A | |||
SPRY2 | P18, P144, P160 | Unoxidised | 7 | N/A | N/A | N/A | |
TELO2 | P374, P419, P422 | Unoxidised | 47 | N/A | N/A | N/A | |
THRA | P160*, P162* | Unoxidised | 20 | N/A | N/A | N/A | |
TP53 | P142, P359 | Unoxidised | 7 | N/A | N/A | N/A | |
|
Total | Pro | 67 | 8 | 11 | 0 | |
Met | 4610 | 676 | 4131 | 426 | |||
Other | 361 | 58 | 62 | 7 | |||
Unoxidised | 13154 | 0 | 0 | 0 | |||
All | 18192 | 742 | 4204 | 433 |
*Doubly oxidised peptides were interrogated when multiple prolyl hydroxylation sites had been reported on the same tryptic peptide.